Identification of survival motor neuron as a transcriptional activator-binding protein
- PMID: 10369867
- DOI: 10.1093/hmg/8.7.1219
Identification of survival motor neuron as a transcriptional activator-binding protein
Abstract
Spinal muscular atrophy (SMA) is an inherited neuro-muscular disease characterized by specific degeneration of spinal cord anterior horn cells and subsequent muscle atrophy. Survival motor neuron ( SMN ), located on chromosome 5q13, is the SMA-determining gene. In the nucleus, SMN is present in large foci called gems, the function of which is not yet known, while cytoplasmic SMN has been implicated in snRNP biogenesis. In SMA patients, SMN protein levels and the number of gems generally correlate with disease severity, suggesting a critical nuclear function for SMN. In a screen for proteins associated with the nuclear transcription activator 'E2' of papillomavirus, two independent SMN cDNAs were isolated. The E2 and SMN proteins were found to associate specifically in vitro and in vivo. Expression of SMN enhanced E2-dependent transcriptional activation, and patient-derived SMN missense mutations reduced E2 gene expression. Our results demonstrate that SMN interacts with a nuclear transcription factor and imply that SMN may serve a role in regulating gene expression. These observations suggest that SMA may in part result from abnormal gene expression and that E2 may influence viral gene expression through SMN interaction.
Similar articles
-
The survival motor neuron protein in spinal muscular atrophy.Hum Mol Genet. 1997 Aug;6(8):1205-14. doi: 10.1093/hmg/6.8.1205. Hum Mol Genet. 1997. PMID: 9259265
-
Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy.Nature. 1997 Nov 27;390(6658):413-7. doi: 10.1038/37144. Nature. 1997. PMID: 9389483
-
Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems.J Cell Biol. 1999 Dec 13;147(6):1181-94. doi: 10.1083/jcb.147.6.1181. J Cell Biol. 1999. PMID: 10601333 Free PMC article.
-
Therapeutics development for spinal muscular atrophy.NeuroRx. 2006 Apr;3(2):235-45. doi: 10.1016/j.nurx.2006.01.010. NeuroRx. 2006. PMID: 16554261 Free PMC article. Review.
-
Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.Neuron. 2005 Dec 22;48(6):885-96. doi: 10.1016/j.neuron.2005.12.001. Neuron. 2005. PMID: 16364894 Review.
Cited by
-
A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.J Cell Biol. 2003 Jan 6;160(1):41-52. doi: 10.1083/jcb.200208079. Epub 2003 Jan 6. J Cell Biol. 2003. PMID: 12515823 Free PMC article.
-
Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model.RNA Biol. 2011 Jul-Aug;8(4):600-6. doi: 10.4161/rna.8.4.16224. Epub 2011 Jul 1. RNA Biol. 2011. PMID: 21654213 Free PMC article.
-
Epstein-Barr virus nuclear antigen 2 binds via its methylated arginine-glycine repeat to the survival motor neuron protein.J Virol. 2003 Apr;77(8):5008-13. doi: 10.1128/jvi.77.8.5008-5013.2003. J Virol. 2003. PMID: 12663808 Free PMC article.
-
Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter.J Virol. 2001 Dec;75(23):11781-90. doi: 10.1128/JVI.75.23.11781-11790.2001. J Virol. 2001. PMID: 11689659 Free PMC article.
-
Enhanced expression of the central survival of motor neuron (SMN) protein during the pathogenesis of osteoarthritis.J Cell Mol Med. 2014 Jan;18(1):115-24. doi: 10.1111/jcmm.12170. Epub 2013 Nov 17. J Cell Mol Med. 2014. PMID: 24237934 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
